Childhood bullous pemphigoid: a case report and 10-year follow up

Ana María Sáenz1, Francisco González, Antonietta Cirocco

  • 1Department of Dermatology, Hospital Universitario de Caracas, Luis Razetti School of Medicine, Central University of Venezuela, Caracas, Venezuela. anamariasa@cantv.net

Insights

Bullous pemphigoid (BP) is a rare autoimmune blistering disease in children. This case study details a 15-month-old boy successfully treated with steroids, showing complete remission after a decade.

Area of Science:

  • Pediatric Dermatology
  • Immunodermatology
  • Autoimmune Blistering Diseases

Background:

  • Bullous pemphigoid (BP) is an acquired autoimmune blistering disease typically affecting the elderly.
  • Pediatric bullous pemphigoid is exceptionally rare, with limited case reports in literature.

Observation:

  • A 15-month-old boy presented with widespread tense bullae on the trunk, limbs, palms, soles, and oral mucosa.
  • Clinical presentation mimicked other pediatric blistering conditions, necessitating thorough investigation.

Findings:

  • Histopathological and direct immunofluorescence studies confirmed the diagnosis of bullous pemphigoid.
  • The patient demonstrated a significant clinical response to systemic corticosteroid therapy.

Implications:

  • This case highlights the importance of considering bullous pemphigoid in the differential diagnosis of pediatric blistering disorders.
  • Early diagnosis and appropriate treatment, such as systemic steroids, can lead to favorable long-term outcomes and potential remission in pediatric BP.
  • Long-term follow-up is crucial for monitoring disease course and ensuring sustained remission in affected children.